MedPath

A 12-Week Home-Based Electrical Stimulation Program for Strength in Adults With Knee Osteoarthritis

Not Applicable
Terminated
Conditions
Osteoarthritis
Osteoarthritis, Knee
Registration Number
NCT05765435
Lead Sponsor
Cionic, Inc.
Brief Summary

The purpose of this research is to investigate if a 12-week program of stimulation assisted activities can combat disuse atrophy for individuals diagnosed with knee osteoarthritis (KOA). This study will use a home-based medical device to administer electrical stimulation and measure its effect on outcomes that include quadriceps strength, perceived functional capacity, pain, and walking performance. It was hypothesized that stimulation assisted activities will show larger muscle mass and strength improvements; improved gait kinematics, pain and perceived function; and a high compliance to the assigned program compared to no stimulation.

Detailed Description

The study aims to evaluate the Cionic Neural Sleeve for subjects diagnosed with KOA. All participants will be assigned a Cionic Neural Sleeve to wear on the most impacted leg and be prescribed a home-based exercise and walking program. Participants will be randomly assigned into three groups: (a) control; (b) neuromuscular electrical stimulation (NMES); (c) NMES and functional electrical stimulation (FES). The control group will not receive stimulation for the exercise and walking program, whereas participants in the NMES group will receive stimulation during exercises, and participants in the NMES and FES group will receive stimulation during exercises and walking. The primary outcome measures include quadriceps strength and perceived pain. Exploratory outcome measures include adherence to the program, thigh muscle volume, functional ability of the lower limb, walking performance, perceived functional capacity, and perceived quality of life.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
6
Inclusion Criteria
  1. Persons with knee osteoarthritis between the ages of 22 and 75
  2. Ability to walk a duration of 30 minutes per walking session (with or without an assistive device), for three days per week
  3. Able to tolerate the device for up to 1 hour per lab session
  4. No recent change in medication or exacerbation of symptoms over the last 60 days
  5. Radiographic KOA Kellgren and Lawrence grade 2 or 3 or physician diagnosed mild or moderate KOA if radiographic imaging is not available
  6. No hyaluronic acid or cortisone injection into knees in previous 12 months
Exclusion Criteria
  1. Lower motor neuron disease or injury (e.g. peripheral neuropathy) that may impair response to stimulation
  2. Absent sensation in the impacted or more impacted leg
  3. Inadequate response to stimulation, as defined as inability to achieve muscle contraction or tolerate stimulation
  4. Inability to ambulate with the sleeve in place of an ankle foot orthosis (AFO)/knee ankle foot orthosis (KAFO) if utilized
  5. Use of FES devices in the past year
  6. Demand-type cardiac pacemaker or defibrillator
  7. Malignant tumor in the impacted or more impacted leg
  8. Existing thrombosis in the impacted or more impacted leg
  9. Fracture or dislocation in the impacted or more impacted leg that could be adversely affected by motion from stimulation
  10. History of knee replacement surgery
  11. History of other types of arthritis
  12. History of neurological disease
  13. History of seizures or diagnosed with epilepsy/seizures
  14. Current pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Average Maximal Voluntary Isometric Contraction of the Quadriceps From BaselineBaseline, 6 weeks, 12 weeks

Strength assessment of the quadriceps muscles using a handheld dynamometer, measured in Newtons. Subjects performed 3 repetitions of maximal effort, separated by two minutes of rest between each. The average of the 3 repetitions was recorded as the subjects' 1 repetition maximum. A positive change indicates increased quadriceps strength.

Change in Perceived Pain Scores From BaselineBaseline, 6 weeks, 12 weeks

Western Ontario/McMaster Universities Osteoarthritis Index (WOMAC) pain questionnaire to measure perceived pain, measured by score. Scores on the WOMAC pain subscale range from 0 to 20, with high scores indicative of worse pain. A positive change indicates improvement.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cionic, Inc.

🇺🇸

San Francisco, California, United States

Cionic, Inc.
🇺🇸San Francisco, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.